3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with pyrazines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kindler, S; Zohar, J | 1 |
| Appleyard, SM; Cui, RJ; Roberts, BL; Zhao, H; Zhu, M | 1 |
1 trial(s) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and pyrazines
| Article | Year |
|---|---|
Update of the serotonergic hypothesis of obsessive compulsive disorder.
Topics: Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Piperazines; Pyrazines; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin Antagonists | 1992 |
1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and pyrazines
| Article | Year |
|---|---|
Serotonin activates catecholamine neurons in the solitary tract nucleus by increasing spontaneous glutamate inputs.
Topics: Action Potentials; Animals; Catecholamines; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Glutamic Acid; Male; Mice; Neurons; Patch-Clamp Techniques; Piperazines; Pyrazines; Quinoxalines; Receptors, Presynaptic; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Receptor Agonists; Solitary Nucleus; Tyrosine 3-Monooxygenase | 2012 |